Nyxoah (Belgium)
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat OSA. Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. In order to support our continuous expansion, Nyxoah is actively looking for some talented an
Basic Information
- Category: business
- Website: https://www.nyxoah.com/
Documented Facts
- Email: jobs@nyxoah.com (No linked source recorded for this statement.)
Evidence and Sources
- Nyxoah (Belgium) — Official Site (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Nyxoah (Belgium).
- Canonical profile: https://brandsource.ai/brands/nyxoah-belgium
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/nyxoah-belgium/json-ld
- Citation profile API: https://brandsource.ai/api/brands/nyxoah-belgium/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (77/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat OSA. Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. In order to support our continuous expansion, Nyxoah is actively looking for some talented an
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.